Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colitis, Ulcerative × peficitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 1 Lymphoma, Follicular 1 Colitis, Ulcerative 1

Interventions

pembrolizumab 1 peficitinib 1 Vitamin E 1 Specimen Handling 1 Nivolumab 1 NX-13 1 Methylprednisolone 1 Medical Marijuana 1 Iron-Dextran Complex 1 Colonoscopy 1 Biopsy 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01959282 2019-01-04

A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Janssen Research & Development, LLC

Phase 2 Completed

Colitis, Ulcerative, Lymphoma, Follicular, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡